Carlsmed, Inc. To Participate in the 25th Annual Needham Virtual Conference

Rhea-AI Summary

Carlsmed (Nasdaq: CARL) announced that CEO and Chairman Mike Cordonnier will present at the 25th Annual Needham Virtual Conference on April 13, 2026 at 11:45 AM ET.

A live webcast will be available to registered participants, and a replay will be posted after the presentation.

News Market Reaction – CARL

+1.04%

6 alerts

+1.04% Session close to close

+4.2% Peak in 5 hr 15 min

$263.04M Market Cap

1.2x Rel. Volume

In the Apr 2 session, CARL gained 1.04%, reflecting a mild positive market reaction. Argus tracked a peak move of +4.2% during that session. Our momentum scanner triggered 6 alerts that day, indicating moderate trading interest and price volatility.

Data tracked by StockTitan Argus on the day of publication.

Market Context

This announcement highlights Carlsmed’s continued engagement with the investment community through a...

Analysis

This announcement highlights Carlsmed’s continued engagement with the investment community through a Needham Virtual Conference presentation on April 13, 2026 at 11:45 AM ET. It follows recent news of rapid 2025 revenue growth to $50.5M, expanding gross margins, and first‑in‑human procedures for new spine devices. Investors may monitor future updates on commercialization progress, profitability trends, insider activity, and additional clinical data as key indicators of how this visibility translates into long‑term performance.

Key Figures

Conference date: April 13, 2026 Presentation time: 11:45 AM ET

2 metrics

Conference date April 13, 2026 Needham Virtual Conference presentation date

Presentation time 11:45 AM ET Scheduled time of Needham Virtual Conference presentation

Historical Context

5 past events · Latest: Feb 25 (Positive)

Pattern 5 events

Date	Event	Sentiment	24h Move	Catalyst
Feb 25	Earnings results	Positive	-3.8%	Reported strong Q4 and 2025 growth with higher margins and 2026 guidance.
Feb 23	Conference appearance	Neutral	+0.1%	Announced CEO presentation at 2026 Canaccord Genuity Musculoskeletal Conference.
Feb 18	Clinical milestone	Positive	+5.6%	First personalized cervical plating procedure using corra™ ahead of launch.
Feb 11	Earnings date set	Neutral	-5.8%	Scheduled Q4 and full‑year 2025 results call and webcast details.
Feb 10	Product procedure	Positive	-0.1%	First aprevo® bi‑lateral posterior lumbar fusion procedure before full launch.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

Product and clinical milestones often saw aligned or positive reactions, while strong earnings and scheduling announcements sometimes coincided with negative moves.

Recent Company History

Over recent months, Carlsmed reported strong growth, with Q4 2025 revenue $15.2M and full‑year 2025 revenue $50.5M, plus expanding gross margins and 2026 guidance of $70–$75M. Product milestones included first procedures using the corra™ cervical plating system and aprevo® bi‑lateral posterior lumbar system, ahead of planned 2026 commercial launches. The company also frequently announced participation in industry conferences. Today’s Needham Virtual Conference appearance fits this pattern of ongoing investor and clinical visibility rather than a new financial or regulatory catalyst.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

CARLSBAD, Calif., April 01, 2026 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (Nasdaq: CARL) (“Carlsmed” or the “Company”), today announced that Mike Cordonnier, CEO and Chairman, will be presenting at the 25th Annual Needham Virtual Conference on April 13, 2026 at 11:45 AM ET.

A live webcast will be available to registered participants. Following the presentation, the webcast replay will be available at https://event.summitcast.com/view/cCMfZsH5ZqrwSNTwfC9JDv/RczDxtnmshQKpi2ivHQcH3

About Carlsmed, Inc.

Carlsmed is a medical technology company pioneering AI-enabled personalized spine surgery solutions with a mission to improve outcomes and decrease the cost of healthcare for spine surgery and beyond.

Investor Relations
Caroline Corner, PhD
IR@Carlsmed.com

Media
LeAnn Burton
Senior Director Brand Marketing
LBurton@Carlsmed.com

FAQ

When will Carlsmed (CARL) present at the Needham Virtual Conference in 2026?

Carlsmed will present on April 13, 2026 at 11:45 AM ET, delivering remarks to investors and analysts. According to the company, the session will include a live webcast for registered participants and a replay will be posted after the presentation for later viewing.

Who from Carlsmed (CARL) will speak at the April 13, 2026 Needham conference?

Mike Cordonnier, Carlsmed's CEO and Chairman, will present at the event on April 13, 2026 at 11:45 AM ET. According to the company, Cordonnier will discuss recent developments and engage with conference attendees during a live webcast and replay.

How can investors watch Carlsmed's (CARL) Needham conference presentation on April 13, 2026?

Investors can watch via a live webcast available to registered participants during the April 13, 2026 presentation. According to the company, a replay will be posted afterward at the event's webcast URL for those unable to attend live.

Will Carlsmed (CARL) provide a replay of its April 13, 2026 Needham presentation?

Yes. A webcast replay will be available after the April 13, 2026 presentation for later viewing by interested parties. According to the company, the replay link will be posted on the event webcast page for registered participants and the public to access.

What time is the Carlsmed (CARL) presentation at the 25th Needham Virtual Conference?

The presentation is scheduled for April 13, 2026 at 11:45 AM Eastern Time and will be delivered by the CEO and Chairman. According to the company, a live webcast will stream the session and a replay will be posted afterward.